Begin main content

Reports

We found 5277 result(s)

Quinagolide hydrochloride (Norprolac)

Last Updated: November 23, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Quinagolide hydrochloride
Indications: Hyperprolactinemia

  • Brand Name: Norprolac
  • Manufacturer: Ferring Pharmaceuticals
  • Project Number: S0046
  • Project Status: Complete
  • Submission Type: Resubmission

Health Technology Update — Issue 1

Published on: November 11, 2005
Result type: Reports
Product Line: Health Technology Update

The mandate of the Canadian Coordinating Office for Health Technology Assessment (CCOHTA) has always included the identification and assessment of new and emerging health technologies that may have a significant impact on health care in Canada. In this Issue: New treatment for sleep apnea A minimally invasive surgical treatment for obstructive s...

Emerging Drug List — Bexxar® for Non-Hodgkin's Lymphoma

Published on: October 27, 2005
Result type: Reports
Product Line: Emerging Drug List

Tags

Treatment, Lymphoma, Non-Hodgkin Lymphoma, Iodine, Lymphoma, Non-Hodgkin, Lymphoma, Non-Hodgkin's, Lymphoma, Non-Hodgkins, Lymphoma, therapy, therapies, treatments, Bexxar, iodine-131 anti-B1 antibody, 131I anti-B1, I-131 anti-B1 antibody, iodine-131 anti-B1 monoclonal antibody, iodine-131-labeled anti-CD20 antibody, tositumomab, Non-Hodgkin, non-Hodgkin's, non-hodgkins, nonhodgkin's lymphoma, nonhodgkins non-Hodgkin's lymphoma, Thérapie, thérapies, traitement, traitements, anticorps anti-B1 marqué à l'iode 131, Iodine-131-anti-B1, anticorps anti-CD20 marqué à l'iode 131, lymphome non hodgkinien

Efalizumab (Raptiva)

Last Updated: October 25, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Efalizumab
Indications: Psoriasis, moderate to severe chronic plaque

  • Brand Name: Raptiva
  • Manufacturer: Serono Canada Inc.
  • Project Number: S0043
  • Project Status: Complete
  • Submission Type: New

CT and MRI for Selected Clinical Disorders: a Systematic Review of Clinical Systematic Reviews

Published on: October 21, 2005
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Technology Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). Disease This report explores 13 conditions for which the use of CT and MRI remain controversial: arteriovenous malformations carotid artery disease, cerebral aneurysms, coronary artery disease, headaches, head injuries, lung cancer screening, peripheral vascular disease, p...

Tags

Review Literature, Magnetic Resonance Imaging, MR Tomography, fMRI, Magnetic Resonance Spectroscopy, MR Spectroscopy, NMR Spectroscopy, Nuclear Magnetic Resonance, Tomography, Meta-Analysis, Tomography, X-Ray Computed, MRI, CT scan, Revue de la littérature, systematic review, Systematic overview, Imagerie par résonance magnétique, MR Imaging, Spectroscopie résonance magnétique nucléaire, X-Ray Computed, Zonographie, tomographie, CT, Computed Tomography, CT Scanner, Méta-analyse, Meta analysis

Roflumilast for Asthma and Chronic Obstructive Pulmonary Disease

Published on: October 21, 2005
Result type: Reports

Roflumilast is an inhibitor of phosphodiesterase-IV (PDE4), a cellular enzyme that is linked to airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). n clinical trials, roflumilast produced significant improvements in FEV1 (forced expiratory volume in one second) and PEF (peak expiratory flow) compared wit...

Tags

Treatment, Asthma, Pulmonary Disease, COPD, Chronic Obstructive Pulmonary Disease, Pulmonary Disease, Chronic Obstructive, Asthma, COPD, therapy, therapies, treatments, Daxas, roflumilast, B9302-107, BY217, BYK20869, Chronic Obstructive

Pegaptanib sodium (Macugen)

Last Updated: October 20, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Pegaptanib sodium
Indications: Macular degeneration, age-related

  • Brand Name: Macugen
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: S0044
  • Project Status: Complete
  • Submission Type: New

Niacin/lovastatin (Advicor)

Last Updated: October 18, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Niacin/lovastatin
Indications: Hypercholesterolemia and mixed dyslipidemia

  • Brand Name: Advicor
  • Manufacturer: Oryx Pharmaceuticals Inc.
  • Project Number: S0042
  • Project Status: Complete
  • Submission Type: New

Insulin aspart/insulin aspart protamine (NovoMix 30)

Last Updated: October 13, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Insulin aspart/insulin aspart protamine
Indications: Diabetes mellitus

  • Brand Name: NovoMix 30
  • Manufacturer: Novo Nordisk Canada Inc.
  • Project Number: S0041
  • Project Status: Complete
  • Submission Type: New

Omalizumab (Xolair)

Last Updated: October 13, 2005
Result type: Reports
Product Line: Common Drug Review
Generic Name: Omalizumab
Indications: Asthma, severe persistent

  • Brand Name: Xolair
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: S0045
  • Project Status: Complete
  • Submission Type: Resubmission